HOME >> BIOLOGY >> NEWS
Built-in 'failsafe' device blocks abnormal growth of new blood vessels

CHICAGO --- Some inhibitors of angiogenesis prevent new blood vessel growth by triggering a built-in "failsafe" device in vessel-forming endothelial cells that marks them for apoptosis, or programmed cell death, according to a study from The Feinberg School of Medicine at Northwestern University and Washington University at St. Louis.

By identifying the molecular mechanisms that control this failsafe device, it may be possible to design new anti-angiogenic drugs or to improve already existing drugs to prevent abnormal blood vessel growth, says Olga Volpert, assistant professor of urology at the Feinberg School and lead author the study, which appeared in the April issue of the journal Nature Medicine.

Angiogenesis, or aberrant growth of new blood vessels, enables cancerous tumors to spread through the body and also causes diabetic retinopathy and macular degeneration, the leading causes of blindness in the Western world.

Research has shown that new blood vessel growth relies on an exquisite balance of proteins that either induce or inhibit new growth of the endothelial cells that form the walls of new blood vessels. Identifying the components that influence this balance thus has major scientific relevance for understanding angiogenesis-dependent diseases and for developing therapies to prevent neovascularization.

When certain natural inhibitors are administered as drugs against angiogenesis-dependent diseases like cancer and diabetic retinopathy, they selectively destroy only newly formed vessels, not preexisting ones -- for reasons that were unclear until now.

In the study, endothelial cells activated by an inducer expressed a cell surface protein receptor called Fas, which made the cells sensitive to the inhibitors in their environment. The inhibitors, thrombospondin-1 (TSP1) or pigment epithelial-derived factor (PEDF), activated its ligand, another cell surface protein called FasL -- which fits into the Fas re
'"/>

Contact: Elizabeth Crown
e-crown@northwestern.edu
312-503-8928
Northwestern University
11-Apr-2002


Page: 1 2

Related biology news :

1. Built-in eyeshade offers clue to prehistoric past
2. Groundbreaking research could ignite new solutions to heat transfer in nano-devices
3. University of Pittsburgh medical center among first to implant heart assist device
4. University of Pittsburgh receives NIH funding to develop heart assist device for infants
5. New database aids medical device exporters
6. Ancient Greeks help scientists build environmentally friendly nano devices
7. Tanning devices - Fast track to skin cancer?
8. New device can help defend against novel biological agents
9. Respiratory-pacing device found beneficial in heart failure
10. Microbes related to infant lung infections reduced using specialized ventilation system device
11. Georgia Tech researchers use lab cultures to control robotic device

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... , ... February 26, 2020 ... ... that its patent-pending Rebound PRP™ and Rebound PRF® devices are now available ... new generation of regenerative medical devices, that will provide the most affordable, ...
(Date:2/28/2020)... ... 27, 2020 , ... Regen Suppliers is now offering the top FDA Cleared ... products are not only one of the only FDA Cleared options available, there ... increasing exponentially in popularity, as they represent an excellent nonoperative method of reducing wrinkles ...
(Date:2/28/2020)... ... February 28, 2020 , ... Regen Suppliers is now ... all available stem cell and exosome biologics. , Regen Suppliers offers an extensive ... kits, adipose kits, PDO thread lifts and more. The company is truly ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... , ... February 20, 2020 ... ... exquisite capability to perform complex, efficient and elegant chemistry. Humans have been ... to our own goals. , Through rapidly evolving technologies and strategies for ...
(Date:2/19/2020)... ... February 18, 2020 , ... ... microbiome populations down to the strain level, recently unveiled a novel DNA isolation ... efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous fixation ... Unlike extension block design, the Inspan device fixates the spine to allow ...
(Date:2/5/2020)... BEACH, Fla. (PRWEB) , ... February 05, 2020 , ... ... an annual observance, sponsored by The National Organization for Rare Disorders (NORD), to raise ... patients’ lives ( rarediseaseday.org ). The Balancing Act’s “Behind The Mystery” rare ...
Breaking Biology Technology:
Cached News: